Gilead Tries to Justify the Huge Price Tag for Remdesivir

KCBS Radio: On-Demand
Tuesday, June 30th
Drugmaker Gilead is justifying the price it's setting for potential Covid-19 treatment drug remdesivir by saying it could save those who take it approximately $12,000 in other hospital charges. 

They've set the price at more than $2,000 for government agencies and over $3,000 for private insurers per treatment.

David Lazarus is Business Columnist for the LA Times. He's written about this, KCBS news anchor Susan Leigh Taylor spoke with him about it.
00:03:58